Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer

被引：0
|
作者：
Axel Muendlein
Bettina H. Rohde
Klaus Gasser
Anton Haid
Stephanie Rauch
Elena Kinz
Heinz Drexel
Wera Hofmann
Verena Schindler
Rita Kapoor
Thomas Decker
Alois H. Lang
机构：
[1] Vorarlberg Institute for Vascular Investigation and Treatment,
[2] GATC Biotech AG,undefined
[3] Academic Teaching Hospital Feldkirch,undefined
[4] LifeCodexx AG,undefined
[5] Onkologie Ravensburg,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词：
Triple-negative breast cancer; BRCA1; BRCA2; Genetic testing; Guidelines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2005 / 2012
页数：7
相关论文
共 50 条
  • [1] Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer
    Muendlein, Axel
    Rohde, Bettina H.
    Gasser, Klaus
    Haid, Anton
    Rauch, Stephanie
    Kinz, Elena
    Drexel, Heinz
    Hofmann, Wera
    Schindler, Verena
    Kapoor, Rita
    Decker, Thomas
    Lang, Alois H.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2005 - 2012
  • [2] Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer.
    Muendlein, Axel
    Rhode, Bettina
    Gasser, Klaus
    Kinz, Elena
    Drexel, Heinz
    Hofmann, Wera
    Schindler, Verena
    Kapoor, Rita
    Decker, Thomas
    Lang, Alois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Evaluation of BRCA1/2 mutation prevalence in Korean women with triple-negative breast cancer
    Lee, A. S.
    Kang, E. Y.
    Baek, H.
    Chae, S.
    Kim, E-K.
    Kim, S. W.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 16 - 16
  • [4] Prevalence of BRCA1 mutations among 284 women with triple-negative breast cancer
    Fostira, F.
    Tsitlaidou, M.
    Gogas, H.
    Pertesi, M.
    Yannoukakos, D.
    Bournakis, E.
    Karavassilis, V.
    Skarlos, P.
    Konstantopoulou, I.
    Fountzilas, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    SR Young
    Robert T Pilarski
    Talia Donenberg
    Charles Shapiro
    Lyn S Hammond
    Judith Miller
    Karen A Brooks
    Stephanie Cohen
    Beverly Tenenholz
    Damini DeSai
    Inuk Zandvakili
    Robert Royer
    Song Li
    Steven A Narod
    [J]. BMC Cancer, 9
  • [6] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    Young, S. R.
    Pilarski, Robert T.
    Donenberg, Talia
    Shapiro, Charles
    Hammond, Lyn S.
    Miller, Judith
    Brooks, Karen A.
    Cohen, Stephanie
    Tenenholz, Beverly
    DeSai, Damini
    Zandvakili, Inuk
    Royer, Robert
    Li, Song
    Narod, Steven A.
    [J]. BMC CANCER, 2009, 9
  • [7] The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
    Villarreal-Garza, C.
    Weitzel, J. N.
    Llacuachaqui, M.
    Sifuentes, E.
    Magallanes-Hoyos, M. C.
    Gallardo, L.
    Alvarez-Gomez, R. M.
    Herzog, J.
    Castillo, D.
    Royer, R.
    Akbari, Mohammad
    Lara-Medina, F.
    Herrera, L. A.
    Mohar, A.
    Narod, S. A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 389 - 394
  • [8] The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
    C. Villarreal-Garza
    J. N. Weitzel
    M. Llacuachaqui
    E. Sifuentes
    M. C. Magallanes-Hoyos
    L. Gallardo
    R. M. Alvarez-Gómez
    J. Herzog
    D. Castillo
    R. Royer
    Mohammad Akbari
    F. Lara-Medina
    L. A. Herrera
    A. Mohar
    S. A. Narod
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 389 - 394
  • [9] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [10] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    [J]. LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
12345